calciphylaxis


Also found in: Dictionary, Encyclopedia, Wikipedia.

calciphylaxis

 [kal″sĭ-fĭ-lak´sis]
a condition of induced hypersensitivity characterized by formation of calcified tissue in response to administration of a challenging agent.

cal·ci·phy·lax·is

(kal'si-fī-lak'sis),
A condition of induced systemic hypersensitivity in which tissues respond to appropriate challenging agents with a sudden, but sometimes evanescent, local calcification. Clinical findings include painful, ischemic tissue necrosis with a black eschar on a red to purple reticulated background. Serum calcium-phosphorus product is elevated; secondary hyperparathyroidism is frequently seen. X-rays show calcification of blood vesels in the involved areas.

calciphylaxis

A condition characterised by calcification of the media of muscular arteries, deep tissues and skin in patients with chronic renal failure, which is often accompanied by intimal hyperplasia, thrombosis and necrotising skin ulcers and secondary hyperparathyroidism.

cal·ci·phy·lax·is

(kal'si-fī-lak'sis)
A condition of induced systemic hypersensitivity in which tissues respond to appropriate challenging agents with a sudden, but sometimes evanescent, local calcification.
Mentioned in ?
References in periodicals archive ?
Calciphylaxis: A devastating complication of derangements of calcium-phosphorus metabolism- A case report and review of the literatura.
Use of sodium thiosulphate in a multi-interventional setting for the treatment of calciphylaxis in dialysis patients.
Sato, "A case-control study of calciphylaxis in Japanese end-stage renal disease patients," Nephrology Dialysis Transplantation, vol.
Wong, "Calciphylaxis in patients on hemodialysis: a prevalence study," Surgery, vol.
Calciphylaxis: fatal complication of cardiometabolic syndrome in patients with end stage kidney disease.
(2.) Kalajian AH, Malhotra PS, Callen JP, et al: Calciphylaxis with normal renal and parathyroid function.
Rapid improvement of calciphylaxis after intravenous pamidronato therapy in a patient with chronic renal failure.
Skin diseases that were studied and evaluated are detailed in Table 1 but also included the following: perforating disorders; calciphylaxis; porphyria and pseudoporphyria; onychomycosis; clubbing; horizontal nail ridging; Terry's nail; hypersensitivity rashes; and malignant skin lesions.
Calcific uremic arteriolopathy (CUA) is the preferred and more descriptive term for what was pre viously known as calciphylaxis. It occurs in patients with end stage renal disease.
Calciphylaxis is a rare disorder in patients with chronic renal failure that is characterized by ischemic necrotic skin lesions.
Some reviews were conducted on nursing interventions to achieve patient outcomes on topics such as fatigue interventions (Astroth, Russell, & Welch, 2013); calciphylaxis (Carter & Ratnam, 2013), cannulation outcomes (Harwood et al., 2017), music and anxiety (Kim et al., 2015), and complementary pain therapies (Zins et al., 2018).
Calciphylaxis or calcifc uremic arteriolopathy is a severe complication of advanced chronic kidney disease (CKD) and other risk factors, including female gender, Caucasian race, obesity, diabetes mellitus, systemic autoimmune and liver diseases, elevated levels of calcium-phosphate product, hypercoagulable diseases, and therapy with calcium and vitamin D analogues, warfarin, corticosteroid drugs, and immunosuppressive drugs (1).